ALK-Abelló A/S (OTC:AKBLF – Get Free Report) shares rose 7% on Monday . The company traded as high as $22.08 and last traded at $21.72. Approximately 2 shares traded hands during trading, a decline of 100% from the average daily volume of 742 shares. The stock had previously closed at $20.30.
ALK-Abelló A/S Stock Performance
The stock has a 50 day moving average price of $20.75 and a two-hundred day moving average price of $17.74.
About ALK-Abelló A/S
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.
Further Reading
- Five stocks we like better than ALK-Abelló A/S
- Want to Profit on the Downtrend? Downtrends, Explained.
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- How to Invest in Small Cap Stocks
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.
